LINGBAO Kong PH.D
Professor, Millions of Talent Project Jiangxi Province candidate
1991-1995 Xingyang Normal University, BSc of Biology
2002-2007 Wuhan University, PhD of Microbiology
2007-2008 Postdoctoral scholar, The University of Chicago, USA
2013-2014 Visiting scholar, National institute of infectious disease , Japan
2022-2023 Visiting scholar, National University of Singapore, Singapore
2008-present Professor,College of Bioscience and Engineering, Jiangxi Agricultural University
Research interest
We have been doing the research on viruses, including Hepatitis C Virus. Japanese Encephalitis Virus, Porcine Epidemic Diarrhea virus and African Swine Fever Virus. The specific focus is virus-host interaction, antiviral drug and vaccine.
Selected publications
[1] Wang Y, Li Y, Li M, Wang K, Xiong J, Wang T, Wang Y, Guo Y, Kong L*, Li M*. A Combined Transcriptomic and Proteomic Analysis of Monkeypox Virus A23 Protein on HEK293T Cells. Int J Mol Sci. 2024 Aug 8;25(16):8678.(IF=4.9)
[2] Wang Y, Zhang J, Li M, Jia M, Yang L, Wang T, Wang Y, Kang L, Li M*, Kong L*.Transcriptome and proteomic analysis of mpox virus F3L-expressing cells. Front Cell Infect Microbiol. 2024 Feb 13:14:1354410..(IF=4.6)
[3] Jiang H, Wang T, Kong L*, Li B*, Peng Qi*. Reverse Genetics Systems for Emerging and Re-Emerging Swine Coronaviruses and Applications.Viruses. 2023 Sep 26;15(10):2003. (IF=3.8)
[4] Li Y, Gladue DP, Li S, Deng L, Shen C, Aguilar PV, Wang T, Kong L*. Editorial: Insights of important mammalian viruses: Infection, pathogenesis and drugs. Front Microbiol. 2023 Feb 21;14:1147109. ((IF=4.0)
[5] Feng T, Li M, Zhang L, Li S, Yang Z, Kang L, Guo Y, Kong L*, Wang T*. Immunity of two novel hepatitis C virus polyepitope vaccines. Vaccine. 2022 Oct 12;40(43):6277-6287. (IF=5.5)
[6] Li M, Weng S, Wang Q, Yang Z, Wang X, Yin Y, Zhou Q, Zhang L, Tao F, Li Y, Jia M, Yang L, Xin X, Li H, Kang L, Wang Y*, Wang T*, Li S*, Kong L*. Reduced binding activity of vaccine serum to Omicron Receptor-Binding Domain. Front Immunol 2022 Jul 28;13:960195. (IF=7.3)
[7] Yang Z, Ouyang T, Aoyagi H, Wang T, Xing X, Zhang Y, Wang Y, Li Y, Aizaki H, Li S*, Kong L*. Cellular OCIAD2 protein is a proviral factor for hepatitis C virus replication. Int J Biol Macromol. 2021 Oct 1;188:147-159. (IF=8.02)
[8] Wan J, Wang T, Xu J, Ouyang T, Wang Q, Zhang Y, Weng S, Li Y, Wang Y, Xin X, Wang X, Li S*, Kong L*. Novel Japanese encephalitis virus NS1-based vaccine: Truncated NS1 fused with E. coli heat labile enterotoxin B subunit. EBioMedicine. 2021 May; 67:103353. doi: 10.1016/j.ebiom.2021.103353. (IF=11.2)
[9] Kong L, Aoyagi H, Yang Z, Ouyang T, Matsuda M, Fujimoto A, Watashi K, Suzuki R, Arita M, Yamagoe S, Dohmae N, Suzuki T, Suzuki T, Muramatsu M, Wakita T, Aizaki H*. Surfeit 4 contributes to the replication of hepatitis C virus using double membrane vesicles. J Virol. 2020 Jan 6;94(2). pii: e00858-19. doi: 10.1128/JVI.00858-19. (IF=5.1)
[10] Kong L, Fujimoto A, Nakamura M, Aoyagi H, Matsuda M, Watashi K, Suzuki R, Arita M, Yamagoe S, Dohmae N, Suzuki T, Sakamaki Y, Ichinose S, Suzuki T, Wakita T, Aizaki H*. Prolactin regulatory element binding protein is involved in hepatitis C virus replication compartment by interacting with NS4B. J Virol. 2016 Jan 6;90(6):3093-111. (IF=4.6)
[11] Wang Q, Xin X, Wang T, Wan J, Ou Y, Yang Z, Yu Q, Zhu L, Guo Y, Wu Y, Ding Z, Zhang Y, Pan Z, Tang Y*, Li S*, Kong L*. Japanese Encephalitis Virus Induces Apoptosis and Encephalitis by Activating the PERK Pathway. J Virol. 2019 Aug 13;93(17). (IF=4.5)
[12] Guo F, Yu X, Xu A, Xu J, Wang Q, Guo Y, Wu X, Tang Y, Ding Z, Zhang Y, Gong T, Pan Z, Li S*, Kong L*. Japanese encephalitis virus induces apoptosis by inhibiting Foxo signaling pathway. Vet Microbiol. 2018 Jul;220:73-82.(IF=2.79)
[13] Li S*, Kong L*, Yu X. The expanding roles of endoplasmic reticulum stress in virus replication and pathogenesis. Crit Rev Microbiol. 2015 Jun;41(2):150-64. (IF=8.19)
[14] Li S, Kong L*, Yu X, Zheng Y*. Host-virus interactions: from the perspectives of epigenetics. Rev Med Virol. 2014 Jul;24(4):223-41.(IF= 5.57)
[15] Kong L*, Li S*, Liao Q, Zhang Y, Sun R, Zhu X, Zhang Q, Wang J, Wu X, Fang X, Zhu Y. Oleanolic acid and ursolic acid: novel Hepatitis C virus antivirals that inhibit NS5B activity. Antiviral Res. 2013 Apr;98(1):44-53. (IF=3.43)
[16] Li S, Yu X, Guo Y, Kong L*. Interaction Networks of Hepatitis C Virus NS4B: Implications for Antiviral Therapy. Cell Microbiol 2012 ;14(7):994-1002.(IF= 4.81)
Selected honors and awards
[1] China Association of Returned Scholars (CARS) "Innovation and Entrepreneurship" Competition Prize,2021
[2] Research Awards in Jiangxi Province, 2015, 2010, 2008
Contact information
Tel: + 86 791 83828079
E-mail: lingbaok@hotmail.com, lingbaok@mail.jxau.edu.cn